Longevity, aging and rapamycin
Longevity, aging and rapamycin
About this item
Full title
Author / Creator
Publisher
Basel: Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
Basel: Springer-Verlag
Subjects
More information
Scope and Contents
Contents
The federal drug administration (FDA)-approved compound rapamycin was the first pharmacological agent shown to extend maximal lifespan in both genders in a mammalian species. A major question then is whether the drug slows mammalian aging or if it has isolated effects on longevity by suppressing cancers, the main cause of death in many mouse strain...
Alternative Titles
Full title
Longevity, aging and rapamycin
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4207939
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4207939
Other Identifiers
ISSN
1420-682X
E-ISSN
1420-9071
DOI
10.1007/s00018-014-1677-1
